Abbad-Jaime De Aragón, C.; Davo-Mogica, M.; de la Cruz-Anaya, P.; Berna-Rico, E.; Díaz-Ruiz, I.; Perales-Sánchez, I.; Brownstone, N.D.; Jaén, P.; Puig, L.; Blauvelt, A.;
et al. Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time. J. Pers. Med. 2026, 16, 234.
https://doi.org/10.3390/jpm16050234
AMA Style
Abbad-Jaime De Aragón C, Davo-Mogica M, de la Cruz-Anaya P, Berna-Rico E, Díaz-Ruiz I, Perales-Sánchez I, Brownstone ND, Jaén P, Puig L, Blauvelt A,
et al. Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time. Journal of Personalized Medicine. 2026; 16(5):234.
https://doi.org/10.3390/jpm16050234
Chicago/Turabian Style
Abbad-Jaime De Aragón, Carlota, María Davo-Mogica, Pablo de la Cruz-Anaya, Emilio Berna-Rico, Inés Díaz-Ruiz, Inés Perales-Sánchez, Nicholas D. Brownstone, Pedro Jaén, Lluis Puig, Andrew Blauvelt,
and et al. 2026. "Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time" Journal of Personalized Medicine 16, no. 5: 234.
https://doi.org/10.3390/jpm16050234
APA Style
Abbad-Jaime De Aragón, C., Davo-Mogica, M., de la Cruz-Anaya, P., Berna-Rico, E., Díaz-Ruiz, I., Perales-Sánchez, I., Brownstone, N. D., Jaén, P., Puig, L., Blauvelt, A., & González-Cantero, A.
(2026). Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time. Journal of Personalized Medicine, 16(5), 234.
https://doi.org/10.3390/jpm16050234
